Michael Churchill

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Inhibition of FGF receptor blocks adaptive resistance to RET inhibition in CCDC6-RET –rearranged thyroid cancer”.

Inhibition of FGF receptor blocks adaptive resistance to RET inhibition in CCDC6-RET –rearranged thyroid cancer

The Journal of Experimental Medicine(2022)10.1084/jem.20210390

N/A

0.761DataRank · unranked

18 citations

Jacques A. Villefranc, Timothy M. Ullmann, Jessica W. Thiesmeyer, Viviana Anelli, Jun Yao +26 more

A novel therapeutic bispecific format based on synthetic orthogonal heterodimers enables T cell activity against Acute myeloid leukemia

Oncogene(2022)10.1038/s41388-022-02532-2

N/A

0DataRank · unranked

4 citations

Florence Borot, Xing Du, Michael Churchill, Jian Ding, Albert Mridul Grass +4 more

A novel therapeutic bispecific format based on synthetic orthogonal heterodimers enables T cell activity against Acute Myeloid Leukemia

Research Square(2022)10.21203/rs.3.rs-2135768/v1

N/A

0DataRank · unranked

0 citations

Alan Burke, Florence Borot, Xing Du, Michael Churchill, Jian Ding +4 more